Analysts expect Sharps Compliance Corp. (NASDAQ:SMED) to announce $12.11 million in sales for the current quarter, according to Zacks Investment Research. Three analysts have issued estimates for Sharps Compliance’s earnings, with the highest sales estimate coming in at $12.42 million and the lowest estimate coming in at $11.50 million. Sharps Compliance posted sales of $12.39 million during the same quarter last year, which suggests a negative year over year growth rate of 2.3%. The business is expected to issue its next quarterly earnings report on Wednesday, January 22nd.
On average, analysts expect that Sharps Compliance will report full-year sales of $48.81 million for the current financial year, with estimates ranging from $48.60 million to $49.04 million. For the next year, analysts anticipate that the business will report sales of $52.50 million, with estimates ranging from $51.41 million to $53.60 million. Zacks’ sales calculations are an average based on a survey of sell-side analysts that follow Sharps Compliance.
Sharps Compliance (NASDAQ:SMED) last issued its quarterly earnings data on Wednesday, October 23rd. The industrial products company reported $0.04 EPS for the quarter, topping analysts’ consensus estimates of $0.01 by $0.03. Sharps Compliance had a net margin of 1.74% and a return on equity of 3.16%. The business had revenue of $13.60 million during the quarter, compared to analysts’ expectations of $11.30 million.
Hedge funds have recently added to or reduced their stakes in the stock. Lapides Asset Management LLC lifted its holdings in Sharps Compliance by 13.3% in the 2nd quarter. Lapides Asset Management LLC now owns 164,700 shares of the industrial products company’s stock worth $586,000 after purchasing an additional 19,300 shares during the last quarter. Wells Fargo & Company MN boosted its holdings in Sharps Compliance by 8.3% during the second quarter. Wells Fargo & Company MN now owns 424,814 shares of the industrial products company’s stock valued at $1,512,000 after purchasing an additional 32,600 shares in the last quarter. BlackRock Inc. boosted its holdings in Sharps Compliance by 3.8% during the second quarter. BlackRock Inc. now owns 108,739 shares of the industrial products company’s stock valued at $387,000 after purchasing an additional 4,013 shares in the last quarter. Morgan Stanley grew its stake in shares of Sharps Compliance by 34.3% in the 2nd quarter. Morgan Stanley now owns 188,699 shares of the industrial products company’s stock valued at $672,000 after purchasing an additional 48,199 shares during the period. Finally, North Star Investment Management Corp. grew its stake in shares of Sharps Compliance by 9.8% in the 3rd quarter. North Star Investment Management Corp. now owns 271,575 shares of the industrial products company’s stock valued at $1,127,000 after purchasing an additional 24,150 shares during the period. 18.41% of the stock is owned by institutional investors and hedge funds.
Shares of SMED traded up $0.06 during trading on Monday, reaching $4.25. 929 shares of the company traded hands, compared to its average volume of 22,444. The stock has a 50-day simple moving average of $4.36 and a 200-day simple moving average of $3.88. The stock has a market cap of $67.66 million, a PE ratio of 425.00, a price-to-earnings-growth ratio of 3.21 and a beta of 0.25. Sharps Compliance has a twelve month low of $2.97 and a twelve month high of $5.25. The company has a quick ratio of 1.66, a current ratio of 1.99 and a debt-to-equity ratio of 0.30.
Sharps Compliance Company Profile
Sharps Compliance Corp. provides medical, pharmaceutical, and hazardous waste management services in the United States. It offers Sharps Recovery System for the containment, transportation, treatment, and tracking of medical waste and used healthcare materials generated outside the hospital and health care facility settings; TakeAway Medication Recovery System, a solution that facilitates the proper disposal of unused medications; MedSafe, a solution for the safe collection, transportation, and proper disposal of unwanted and expired prescription medications; and ComplianceTRAC, a Web-based compliance and training program.
Further Reading: Different Options Trading Strategies
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Sharps Compliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sharps Compliance and related companies with MarketBeat.com's FREE daily email newsletter.